Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TIVOZANIB vs TOCILIZUMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

TIVOZANIB vs TOCILIZUMAB: Safety Overview

Metric TIVOZANIB TOCILIZUMAB
Total FAERS Reports 1,395 98,443
Deaths Reported 135 9,543
Death Rate 9.7% 9.7%
Hospitalizations 291 24,039
Average Patient Age 64.4 yrs 52.2 yrs
% Female Patients 28.3% 84.5%
FDA Approval Date Mar 10, 2021 N/A
Manufacturer AVEO Pharmaceuticals, Inc. CELLTRION USA, Inc.
Route ORAL INTRAVENOUS
Marketing Status Prescription Prescription